Suppr超能文献

夹层动脉瘤治疗效果改善。腔内无缝合人工血管。

Improved results for dissecting aneurysms. Intraluminal sutureless prosthesis.

作者信息

Lemole G M, Strong M D, Spagna P M, Karmilowicz N P

出版信息

J Thorac Cardiovasc Surg. 1982 Feb;83(2):249-55.

PMID:6977074
Abstract

Surgical therapy for dissection of the thoracic aorta has had a high mortality. One contributing factor has been hemorrhage from the prosthesis and the suture lines. A method of treatment with an intraluminal prosthesis that requires no end-to-end anastomosis has been developed. We have used this method in 14 patients, of whom eight had acute thoracic aortic dissections and six had chronic dissections. We assembled our own prosthesis in the first five cases but, more recently, we have utilized an intraluminal prosthesis provided by USCI. Eight of the patients had type 1 dissection, of whom five required concomitant aortic valve replacement and three coronary artery bypass grafting; one had a type II dissection and five had type III dissections. The age range was 31 to 71 years with a mean of 58. There were 12 men and 2 women. There were no intraoperative deaths, but one patient died 10 days postoperatively of a perforated ulcer and another died at 6 months of empyema. Follow-up has been from 9 to 51 months with a mean of 22 months. There has been no evidence of compromise of the aortic lumen and no prosthetic problems, such as erosion, migration, or thrombosis. This technique provides a safe and simple way to repair dissecting aneurysms of the thoracic aorta and has provided long-term reliability. We have subsequently used this graft for 11 patients with aneurysm of the aorta with favorable results. We presently recommend this technique for dissecting, atherosclerotic, and Marfanoid aneurysms of the thoracic aorta.

摘要

胸主动脉夹层的外科治疗死亡率一直很高。一个促成因素是假体和缝合线处出血。一种无需端对端吻合的腔内假体治疗方法已经开发出来。我们已将这种方法应用于14例患者,其中8例为急性胸主动脉夹层,6例为慢性夹层。在前5例病例中我们组装了自己的假体,但最近我们使用了USCI提供的腔内假体。8例患者为I型夹层,其中5例需要同期进行主动脉瓣置换,3例需要冠状动脉搭桥术;1例为II型夹层,5例为III型夹层。年龄范围为31至71岁,平均年龄58岁。男性12例,女性2例。术中无死亡病例,但1例患者术后10天死于穿孔性溃疡,另1例患者在6个月时死于脓胸。随访时间为9至51个月,平均22个月。没有主动脉管腔受压的证据,也没有假体问题,如侵蚀、移位或血栓形成。这项技术为修复胸主动脉夹层动脉瘤提供了一种安全、简单的方法,并具有长期可靠性。我们随后将这种移植物用于11例主动脉瘤患者,效果良好。我们目前推荐将这项技术用于胸主动脉夹层、动脉粥样硬化和马方综合征性动脉瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验